4/11
08:06 am
kalv
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $35.00 price target on the stock.
Medium
Report
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $35.00 price target on the stock.
4/11
06:06 am
kalv
Rating for KALV
Low
Report
Rating for KALV
4/11
06:06 am
kalv
Rating for KALV
Low
Report
Rating for KALV
3/11
03:51 pm
kalv
Rating for KALV
Low
Report
Rating for KALV
3/11
03:51 pm
kalv
Rating for KALV
Low
Report
Rating for KALV
2/13
02:16 pm
kalv
Rating for KALV
Low
Report
Rating for KALV
2/13
02:16 pm
kalv
Rating for KALV
Low
Report
Rating for KALV